The National Institutes of Health will fund five more years of research into infectious diseases and biodefense by a group based at UNC-Chapel Hill.

The won a renewal of funding from the National Institute of Allergy and Infectious Diseases, which is part of the NIH.

The center includes staff from UNC-CH’s School of Medicine, Duke University, Emory University, and several other universities and research institutes.

Dr. P. Frederick Sparling, a professor of medicine at UNC-CH, heads the center.

According to UNC-CH, the money will support a staff of more than 50 investigators and support personnel.

Research focuses on emerging infectious diseases as well as defenses against microbial agents that could be used in bioterrorism. End goals include new drugs and vaccines as well as microbes to combat a bioterror incident.